Clinical Trial: Safety and Efficacy of SR-hGH (Sustained-release Human Growth Hormone, Declage Inj.)

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title:

Brief Summary: As studies demonstrate, the administration of recombinant human GH (rhGH) in adults with GH deficiency has been known to improve metabolic impairment and quality of life. Patients, however, do have to tolerate daily injections of GH (rhGH).

Detailed Summary:
Sponsor: LG Life Sciences

Current Primary Outcome: Safety [ Time Frame: 12 weeks ]

Adverse event


Original Primary Outcome: Same as current

Current Secondary Outcome: Efficacy [ Time Frame: 12 weeks ]

QoL-AGHDA


Original Secondary Outcome: Same as current

Information By: LG Life Sciences

Dates:
Date Received: May 22, 2012
Date Started: December 2009
Date Completion:
Last Updated: October 3, 2012
Last Verified: October 2012